NCT00175266View on ClinicalTrials.gov

Islet Transplantation Using Campath-1H and Infliximab Induction

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

Not specified

Conditions
Type 1 Diabetes
Interventions
DRUG

alemtuzumab

PROCEDURE

islet transplant

DRUG

infliximab

Trial Locations (1)

T6G2C8

University of Alberta - Clinical Islet Transplant Program, Edmonton

Sponsors
All Listed Sponsors
collaborator

Juvenile Diabetes Research Foundation

OTHER

lead

University of Alberta

OTHER

NCT00175266 - Islet Transplantation Using Campath-1H and Infliximab Induction | Biotech Hunter | Biotech Hunter